Skip to main
IPEX
IPEX logo

IPEX Market Capitalization Overview

Market Cap: $153.76M as of Dec 3, 2025

$153.76M
$0.00 (0.00%)past month
As of Dec 3, 2025, IPEX has a market capitalization of $153.76M. Over the past 30 days, its market cap has decreased by -0.1%, while in the last 12 months, it has increased by .

Market capitalization represents the total value of Inflection Point Acquisition C as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

IPEX Market Cap Formula = Stock Price * Shares Outstanding

The market cap of IPEX helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

IPEX Market Cap History

DateMarket CapChange
Dec 1, 2025$153.62M-0.10%
Nov 3, 2025$153.76M+0.59%
Oct 1, 2025$152.87M+0.59%
Sep 2, 2025$151.97M+0.30%
Aug 1, 2025$151.53M+0.59%
Jul 1, 2025$150.63M+0.50%
Jun 2, 2025$149.88M+3.33%
May 1, 2025$145.06M+0.10%
Apr 1, 2025$144.91M+36.49%
Mar 7, 2025$106.17M

IPEX End of Year Market Cap History

DateMarket CapChange
2025$153.76M

FAQs About Inflection Point Acquisition C (IPEX) Market Cap

As of Dec 3, 2025, the market capitalization of IPEX is $153.76M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Inflection Point Acquisition C’s market capitalization has increased by 0.0000%, changing from $153.76M to $153.76M as of Dec 3, 2025.

In the last 3 months, Inflection Point Acquisition C’s market capitalization has increased by —, changing from – to – as of –.

In the year –, Inflection Point Acquisition C’s market capitalization increased from – in January to – in December, reflecting a — change.

Inflection Point Acquisition C (IPEX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.